心血管病学进展2024,Vol.45Issue(1) :40-43.DOI:10.16806/j.cnki.issn.1004-3934.2024.01.011

肥厚型心肌病合并心房颤动非药物治疗研究进展

Non-Pharmacological Treatment of Hypertrophic Cardiomyopathy Complicated with Atrial Fibrillation

余淼 汤宝鹏
心血管病学进展2024,Vol.45Issue(1) :40-43.DOI:10.16806/j.cnki.issn.1004-3934.2024.01.011

肥厚型心肌病合并心房颤动非药物治疗研究进展

Non-Pharmacological Treatment of Hypertrophic Cardiomyopathy Complicated with Atrial Fibrillation

余淼 1汤宝鹏1
扫码查看

作者信息

  • 1. 新疆医科大学第一附属医院心脏起搏电生理科,新疆乌鲁木齐 830054
  • 折叠

摘要

心房颤动(房颤)是肥厚型心肌病(HCM)常合并的心律失常,HCM舒张功能障碍、心房纤维化、遗传基因、血流动力学等相关因素促进房颤发生,房颤亦可加重HCM进展.目前HCM合并房颤的非药物治疗包括手术间隔肌切除、酒精室间隔消融、导管消融、双腔起搏器植入等,随着诊疗手段的不断更新仍有很多突破的可能.现就HCM合并房颤的非药物治疗展开综述.

Abstract

Atrial fibrillation(AF)is a common arrhythmia associated with hypertrophic cardiomyopathy(HCM).Factors such as impaired diastolic function,atrial fibrosis,genetic inheritance,and hemodynamic changes contribute to the occurrence of AF,which can also worsen the progression of HCM.Non-pharmacological treatment for HCM with AF currently include surgical septal myectomy,alcohol septal ablation,catheter ablation,and dual-chamber pacemaker implantation.As diagnostic and therapeutic methods continue to advance,there is still potential for many breakthroughs in the non-pharmacological treatment of HCM with AF.This review will focus on the non-pharmacological treatment of HCM with AF.

关键词

肥厚型心肌病/心房颤动/治疗/消融/间隔肌切除

Key words

Hypertrophic cardiomyopathy/Atrial fibrillation/Treatment/Ablation/Septal myectomy

引用本文复制引用

基金项目

国家自然科学基金(82370326)

国家自然科学基金(82260065)

出版年

2024
心血管病学进展
成都市心血管病研究所,成都市第三人民医院

心血管病学进展

CSTPCD
影响因子:0.932
ISSN:1004-3934
参考文献量27
段落导航相关论文